nefopam has been researched along with veratridine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biella, G; Brini, AT; Díaz-Trelles, R; Fernández-Sánchez, MT; Groppetti, A; Manfredi, B; Novelli, A; Sotgiu, ML | 2 |
| Desogus, CM; Fernández-Sánchez, MT; Ferrero-Gutiérrez, A; Groppetti, A; Manfredi, B; Novelli, A; Pérez-Gómez, A; Rossoni, G | 1 |
3 other study(ies) available for nefopam and veratridine
| Article | Year |
|---|---|
Novel effect of nefopam preventing cGMP increase, oxygen radical formation and neuronal death induced by veratridine.
Topics: Analgesics, Non-Narcotic; Animals; Cell Death; Cells, Cultured; Cerebellum; Cyclic GMP; Dose-Response Relationship, Drug; Nefopam; Neurons; Rats; Reactive Oxygen Species; Veratridine | 2001 |
Nefopam, an analogue of orphenadrine, protects against both NMDA receptor-dependent and independent veratridine-induced neurotoxicity.
Topics: Analgesics, Non-Narcotic; Animals; Cells, Cultured; Cerebellum; Dizocilpine Maleate; GABA Agonists; Glutamic Acid; Male; Muscimol; Nefopam; Neurons; Neuroprotective Agents; Neurotoxins; Orphenadrine; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Veratridine | 2002 |
Nefopam is more potent than carbamazepine for neuroprotection against veratridine in vitro and has anticonvulsant properties against both electrical and chemical stimulation.
Topics: Analgesics, Non-Narcotic; Animals; Anticonvulsants; Antitubercular Agents; Calcium Channels, L-Type; Calcium Signaling; Carbamazepine; Cells, Cultured; Cerebellum; Dose-Response Relationship, Drug; Electroshock; Glutamic Acid; Isoniazid; Male; Mice; Nefopam; Neurons; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Seizures; Veratridine | 2007 |